News & Insights Across Asia
US President Trump’s new 100% tariffs on imported pharmaceuticals pressure Asian manufacturers to relocate production or face steep costs, reshaping global supply chains.
The U.S. Biosecure Act mandates pharmaceutical companies to decouple from key Chinese suppliers by 2032, stirring debates over its impact on the global pharmaceutical industry and U.S.-China relations.
The escalating opioid crisis in the United States highlights the urgent need for increased action from authorities to reduce deaths and provide effective treatment for addicts.
